Symbol="ALLR"
AssetType="Common Stock"
Name="Allarity Therapeutics Inc"
Description="Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark."
CIK="1860657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4830000"
EBITDA="-15540000"
PERatio="0.0005"
PEGRatio="None"
BookValue="-12.63"
DividendPerShare="0"
DividendYield="0"
EPS="3917.58"
RevenuePerShareTTM="-0.018"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.531"
ReturnOnEquityTTM="-2.908"
RevenueTTM="-7127000"
GrossProfitTTM="-36348000"
DilutedEPSTTM="3917.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="0.0005"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.659"
EVToRevenue="-"
EVToEBITDA="-0.0989"
Beta="-0.0032"
num_52WeekHigh="2100"
num_52WeekLow="1.61"
num_50DayMovingAverage="3.886"
num_200DayMovingAverage="193.4"
SharesOutstanding="2728800"
DividendDate="None"
ExDividendDate="None"
symbol="ALLR"
open="1.77"
high="1.80"
low="1.62"
price="1.63"
volume="82756.00"
latest_trading_day="2023-08-25"
previous_close="1.77"
change="-0.14"
change_percent="-7.9096%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="2871388"
Change_recent_avg="-0.03"
Delta_recent_avg="0.29"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-3.04"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_negative_thumbnail_id_2="118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="639"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0069.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
